Study of Luseogliflozin against hypertension merger diabetes patients
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jun 2017 Planned End Date changed from 31 May 2017 to 31 Aug 2017.
- 30 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 24 May 2016 New trial record